BioCircuit Technologies
Develops non-invasive electrophysiology devices which monitor, control, and repair peripheral nerves.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
* | $2.4m | Grant | |
| Total Funding | 000k | ||
Related Content
BioCircuit Technologies specializes in advanced nerve repair solutions, primarily through its flagship product, Nerve Tape. This innovative medical device is designed to repair peripheral nerve discontinuities more effectively than traditional microsutures. Nerve Tape is 2.6 times stronger and 4.8 times faster than conventional microsuture repairs, significantly reducing surgery time and improving patient outcomes. The company serves healthcare providers, particularly in the fields of neurosurgery and orthopedics, operating within the medical device market. BioCircuit Technologies generates revenue through the sale of Nerve Tape to hospitals, clinics, and surgical centers. The business model focuses on providing a superior alternative to existing nerve repair methods, thereby enhancing the efficiency and success rates of nerve surgeries.
Keywords: nerve repair, medical device, Nerve Tape, peripheral nerve, microsuture alternative, neurosurgery, orthopedics, healthcare, surgical innovation, patient outcomes.